Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
Adela creates develops technologies centered around detecting high-risk conditions like cancer through routine blood tests.
Verastem is a biopharmaceutical company developing new medicines to improve the lives of patients with RAS/MAPK pathway-driven cancers.
Altis is accelerating clinical trials with AI endpoints so that drug developers can get the best new treatment to patients sooner.
Connexus Therapeutics is a private, venture-backed biotechnology startup.
Helus Pharma is a biopharmaceutical company that develops psychedelic therapeutics for mental health conditions.
Intellia Therapeutics is a genome editing company that develops curative gene-editing treatments.
Leal Therapeutics develops novel therapeutics for patients.
DarioHealth is a digital therapeutics company engaged in the development and commercialization of patented and proprietary technology.
TytoCare is a telehealth platform for AI-powered and on-demand remote medical examinations.
Q32 Bio is a biotechnology company that develops treatments for patients with severe autoimmune and inflammatory diseases.
Erasca is a developer of oncology drugs intended to provide precision oncology options.
Fore Biotherapeutics is a precision oncology company specializing in cancer therapies guided by functional genomics.
Nuvation Bio is a global biopharmaceutical company focusing on unmet needs in oncology.
Triveni Bio is a biotechnology company that develops antibody-based therapeutics for immunological and inflammatory diseases.
Enliven Therapeutics is a precision oncology company developing small molecule therapies to extend and improve patient lives.
Shattuck Labs is a biotechnology company that provides novel class biologic medicines for the treatment of cancer and autoimmune disease.
Apogee Therapeutics is a biotechnology company that offers therapies for immunological and inflammatory disorders.
Whitehawk Therapeutics, a clinical-stage oncology therapeutics firm, applies cutting-edge technologies to well-established tumor biology.
Avalo Therapeutics is a clinical-stage biopharmaceutical company.
vVardis develops oral care and dental treatment products using biomimetic peptide technology to address tooth decay and enamel repair.
Prelude Therapeutics designs and develops small molecule therapies targeting key drivers of cancer cell growth and resistance.
Nucleus RadioPharma is a new company built to ensure cancer patients can access potentially life-saving radiopharmaceuticals.
Terremoto Biosciences is a biotechnology company leveraging the power of lysine-based covalency to develop optimized medicines.
ImageneBio is dedicated to developing therapeutics for patients with immunological, autoimmune and inflammatory diseases
OrbiMed has invested in 288 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
OrbiMed's top investment sectors include Biotechnology, Health Care, Therapeutics, Medical, Life Science. The firm invests across 24 different industry categories.
Among tracked funding rounds, Apogee Therapeutics received $1.3B in a Post-IPO Debt round. OrbiMed's total known invested capital is $31.2B.
OrbiMed's average investment size is $108.2M across its portfolio of 288 companies.
Recent OrbiMed portfolio additions include Adela, Verastem Oncology, Altis Labs, Connexus Therapeutics, Helus Pharma. These companies were founded in 2020 or later.